ARTICLE | Clinical News
Cell culture-based pandemic influenza vaccine regulatory update
April 8, 2013 7:00 AM UTC
Vivalis S.A. (Euronext:VLS, Nantes, France) said Kaketsuken (formerly the Chemo-Sero-Therapeutic Research Institute) submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for a cel...